HERON THERAPEUTICS, INC. /DE/
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.
Funding history
About HERON THERAPEUTICS, INC. /DE/
How much funding has HERON THERAPEUTICS, INC. /DE/ raised?
HERON THERAPEUTICS, INC. /DE/ has raised $30.0M in total funding.
Where is HERON THERAPEUTICS, INC. /DE/ headquartered?
HERON THERAPEUTICS, INC. /DE/ is headquartered in San Diego, CA.
What does HERON THERAPEUTICS, INC. /DE/ do?
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.
What problem does HERON THERAPEUTICS, INC. /DE/ solve?
There are unmet medical needs in acute and oncology care, including chemotherapy-induced nausea/vomiting, postoperative nausea/vomiting, and postoperative pain, with over-reliance on postoperative opioids contributing to the opioid crisis.
What's HERON THERAPEUTICS, INC. /DE/'s solution?
Heron develops and commercializes a portfolio of FDA-approved therapies (SUSTOL, CINVANTI, ZYNRELEF, APONVIE) addressing CINV, PONV, and postoperative pain management.
What makes HERON THERAPEUTICS, INC. /DE/ different?
The company points to patented technologies applying its science to already-approved pharmacological agents, yielding products with distinct FDA-approved delivery formats such as a 2-minute IV injection and a 30-second IV injection.
What makes HERON THERAPEUTICS, INC. /DE/ notable?
A publicly traded biotech (Nasdaq: HRTX) whose board chairman is the Chief Investment Officer of Velan Capital, a healthcare-focused investment firm.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.